Combination therapy is often required in patients with hypertension, and fixed-dose single-
pill combinations have been shown to provide an easier regimen for patients, improving …

Background: Many drugs combinations are available and equally recommended for the
initial treatment of patients with marked blood pressure (BP) elevation and high …

Introduction Hypertension and hypercholesterolaemia are important contributors to the
development and progression of atherosclerosis. The coexistence of these two conditions is …

Background: The introduction of a fixed-dose combination (FDC) is expected to improve
treatment compliance. Methods: There were 181 subjects who were randomized to three …

Objective: Combination therapy may help achieve low-density lipoprotein cholesterol (LDL-
C) goals in high-risk patients. In this respect, the role of Rosuvastatin and Ezetimibe (RE) …

Background The ultimate goal of antihypertensive therapy is cardiovascular risk (CVR)
reduction. The aim of this study was to compare the efficacy and safety of once-daily fixed …

Background Despite recommendations for more intensive treatment and the availability of
several effective treatments, hypertension remains uncontrolled in many patients. Objective …

Current cardiovascular disease prevention strategies are based on the management of
cardiovascular risk as a continuum, redefining the therapeutic goals for each individual …

The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …

Background: According to epidemiological data, patients with both hypertension (HTN) and
dyslipidemia (DYS) often fail to achieve goals for both conditions, despite their increased …